chr20-62475514-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_080473.5(GATA5):āc.8A>Gā(p.Gln3Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00684 in 1,318,038 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0045 ( 0 hom., cov: 33)
Exomes š: 0.0071 ( 47 hom. )
Consequence
GATA5
NM_080473.5 missense
NM_080473.5 missense
Scores
2
8
8
Clinical Significance
Conservation
PhyloP100: 2.25
Genes affected
GATA5 (HGNC:15802): (GATA binding protein 5) The protein encoded by this gene is a transcription factor that contains two GATA-type zinc fingers. The encoded protein is known to bind to hepatocyte nuclear factor-1alpha (HNF-1alpha), and this interaction is essential for cooperative activation of the intestinal lactase-phlorizin hydrolase promoter. In other organisms, similar proteins may be involved in the establishment of cardiac smooth muscle cell diversity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0130209625).
BP6
Variant 20-62475514-T-C is Benign according to our data. Variant chr20-62475514-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 180366.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-62475514-T-C is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 683 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA5 | NM_080473.5 | c.8A>G | p.Gln3Arg | missense_variant | 2/7 | ENST00000252997.3 | NP_536721.1 | |
GATA5 | XM_006723699.3 | c.8A>G | p.Gln3Arg | missense_variant | 2/7 | XP_006723762.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA5 | ENST00000252997.3 | c.8A>G | p.Gln3Arg | missense_variant | 2/7 | 1 | NM_080473.5 | ENSP00000252997.2 |
Frequencies
GnomAD3 genomes AF: 0.00449 AC: 683AN: 152098Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
683
AN:
152098
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00581 AC: 261AN: 44910Hom.: 4 AF XY: 0.00580 AC XY: 152AN XY: 26226
GnomAD3 exomes
AF:
AC:
261
AN:
44910
Hom.:
AF XY:
AC XY:
152
AN XY:
26226
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00714 AC: 8326AN: 1165824Hom.: 47 Cov.: 32 AF XY: 0.00691 AC XY: 3884AN XY: 562400
GnomAD4 exome
AF:
AC:
8326
AN:
1165824
Hom.:
Cov.:
32
AF XY:
AC XY:
3884
AN XY:
562400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00449 AC: 683AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.00402 AC XY: 299AN XY: 74426
GnomAD4 genome
AF:
AC:
683
AN:
152214
Hom.:
Cov.:
33
AF XY:
AC XY:
299
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
27
ExAC
AF:
AC:
423
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | GATA5: PP2, PP3, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 23, 2018 | This variant is associated with the following publications: (PMID: 23040494, 24796370, 22641149) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Likely benign, no assertion criteria provided | clinical testing | Blueprint Genetics | Jul 03, 2014 | - - |
GATA5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 27, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at